Administering chemo ups income for non-salaried oncologists

January 2, 2013
Administering chemo ups income for non-salaried oncologists
Non-salaried oncologists report the potential for increased salaries with the administration of chemotherapy or growth factors for lung or colorectal cancer patients, according to a study published online Dec. 26 in the Journal of Clinical Oncology.

(HealthDay)—Non-salaried oncologists report the potential for increased salaries with the administration of chemotherapy or growth factors for lung or colorectal cancer patients, according to a study published online Dec. 26 in the Journal of Clinical Oncology.

Jennifer L. Malin, M.D., Ph.D., from the University of California at Los Angeles, and colleagues surveyed 480 U.S. oncologists involved in the care of a population-based cohort of patients with lung or colorectal cancer. The authors sought to measure the effects of prescribing chemotherapy or or making referrals to other cancer specialists, hospice, or on medical oncologists' income.

According to the researchers, most oncologists reported that their incomes would be unaffected. But, physicians in fee-for-service practice and those paid a salary with productivity incentives were significantly more likely to report that their income would increase from administering chemotherapy (odds ratios, 7.05 and 7.52, respectively) or administering growth factors (odds ratios, 5.60 and 6.03, respectively), compared with salaried oncologists.

"A substantial proportion of oncologists who are not paid a fixed salary report that their incomes increase when they administer chemotherapy and growth factors," the authors write.

One author disclosed to the pharmaceutical and health insurance industries.

Explore further: Oncologists generally refer to specialized palliative care late

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Oncologists generally refer to specialized palliative care late

October 30, 2012
(HealthDay)—Definitional issues and non-acceptance of patients receiving chemotherapy are the barriers to earlier referral to specialized palliative care (SPC) by oncologists, according to a study published online Oct. ...

Radiation oncologists are discussing infertility risks with young cancer patients

March 8, 2012
More than 80 percent of radiation oncologists discuss the impact of cancer treatments on fertility with their patients of childbearing age, which can lead to improved quality of life for young cancer patients who are living ...

Financial hardship common among colon cancer patients

March 13, 2012
(HealthDay) -- Nearly 40 percent of patients undergoing adjuvant chemotherapy for stage III colon cancer experience financial hardship, even if they have health insurance coverage, according to research published online March ...

Breast cancer patients more satisfied when specialists share care management

December 15, 2011
Patients with breast cancer report greater satisfaction with care when their cancer doctor co-manages their care with other specialists. However, some specialists are more likely than others to share decision-making with ...

What price for a year of life? Cancer specialists offer contradictory advice

April 20, 2012
Cancer doctors prescribe medicines with little consideration of the cost, meaning they don't demand any more benefit (in months of survival) from a very expensive drug than from a less expensive one, a new research report ...

Recommended for you

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Breast cancer gene does not boost risk of death: study

January 12, 2018
Young women with the BRCA gene mutation that prompted actress Angelina Jolie's pre-emptive and much-publicised double mastectomy are not more likely to die after a breast cancer diagnosis, scientists said Friday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.